BackApellis Pharmaceuticals Overview

Apellis Pharmaceuticals Net Income

Profitability analysis for APLS.

Quarterly Net Income

$18.66M
120.23% YoY

As of Mar 2026

Annual Net Income (TTM)

$133.27M
159.58% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...